FDA approves breast cancer device from Dune Medical

01/2/2013 | American City Business Journals · Boston Herald

The FDA has granted Dune Medical Devices premarket approval for its MarginProbe System, which is targeted for immediate U.S. distribution. The device, which has been marketed since 2008 in Europe, is used to aid in the detection of additional tumor cells in women undergoing breast cancer procedures and is intended to decrease the need for further surgeries.

View Full Article in:

American City Business Journals · Boston Herald

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ